nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0272	0.146	CbGbCtD
Olopatadine—CYP3A4—Dapsone—systemic lupus erythematosus	0.0238	0.128	CbGbCtD
Olopatadine—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0206	0.111	CbGbCtD
Olopatadine—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0206	0.111	CbGbCtD
Olopatadine—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0177	0.095	CbGbCtD
Olopatadine—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0174	0.0937	CbGbCtD
Olopatadine—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0165	0.0888	CbGbCtD
Olopatadine—CYP3A4—Prednisone—systemic lupus erythematosus	0.0165	0.0885	CbGbCtD
Olopatadine—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0156	0.0839	CbGbCtD
Olopatadine—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0103	0.0552	CbGbCtD
Olopatadine—S100A2—nephron tubule—systemic lupus erythematosus	0.00879	0.0475	CbGeAlD
Olopatadine—S100A1—connective tissue—systemic lupus erythematosus	0.00836	0.0452	CbGeAlD
Olopatadine—S100A2—skin of body—systemic lupus erythematosus	0.00819	0.0443	CbGeAlD
Olopatadine—S100A1—nephron tubule—systemic lupus erythematosus	0.00809	0.0438	CbGeAlD
Olopatadine—S100A1—skin of body—systemic lupus erythematosus	0.00754	0.0408	CbGeAlD
Olopatadine—S100A2—cortex of kidney—systemic lupus erythematosus	0.00752	0.0407	CbGeAlD
Olopatadine—S100A13—connective tissue—systemic lupus erythematosus	0.00741	0.0401	CbGeAlD
Olopatadine—S100A12—connective tissue—systemic lupus erythematosus	0.00731	0.0396	CbGeAlD
Olopatadine—S100B—connective tissue—systemic lupus erythematosus	0.00722	0.039	CbGeAlD
Olopatadine—S100A1—kidney—systemic lupus erythematosus	0.00711	0.0385	CbGeAlD
Olopatadine—S100A1—cortex of kidney—systemic lupus erythematosus	0.00693	0.0375	CbGeAlD
Olopatadine—S100A13—skin of body—systemic lupus erythematosus	0.00669	0.0362	CbGeAlD
Olopatadine—S100A2—lymphoid tissue—systemic lupus erythematosus	0.00663	0.0359	CbGeAlD
Olopatadine—S100B—skin of body—systemic lupus erythematosus	0.00652	0.0353	CbGeAlD
Olopatadine—S100A2—tendon—systemic lupus erythematosus	0.00624	0.0337	CbGeAlD
Olopatadine—S100A1—tendon—systemic lupus erythematosus	0.00574	0.0311	CbGeAlD
Olopatadine—S100A2—lung—systemic lupus erythematosus	0.00547	0.0296	CbGeAlD
Olopatadine—S100A12—lymphoid tissue—systemic lupus erythematosus	0.00535	0.0289	CbGeAlD
Olopatadine—S100B—lymphoid tissue—systemic lupus erythematosus	0.00528	0.0285	CbGeAlD
Olopatadine—S100A12—bone marrow—systemic lupus erythematosus	0.00487	0.0263	CbGeAlD
Olopatadine—S100A1—nervous system—systemic lupus erythematosus	0.00467	0.0252	CbGeAlD
Olopatadine—S100A1—central nervous system—systemic lupus erythematosus	0.00449	0.0243	CbGeAlD
Olopatadine—S100A13—lung—systemic lupus erythematosus	0.00447	0.0242	CbGeAlD
Olopatadine—S100A12—lung—systemic lupus erythematosus	0.00441	0.0239	CbGeAlD
Olopatadine—S100A13—nervous system—systemic lupus erythematosus	0.00414	0.0224	CbGeAlD
Olopatadine—CYP3A4—urine—systemic lupus erythematosus	0.00412	0.0223	CbGeAlD
Olopatadine—S100B—nervous system—systemic lupus erythematosus	0.00403	0.0218	CbGeAlD
Olopatadine—S100A13—central nervous system—systemic lupus erythematosus	0.00399	0.0216	CbGeAlD
Olopatadine—S100B—central nervous system—systemic lupus erythematosus	0.00388	0.021	CbGeAlD
Olopatadine—CYP3A4—blood plasma—systemic lupus erythematosus	0.00215	0.0116	CbGeAlD
Olopatadine—HRH1—connective tissue—systemic lupus erythematosus	0.00148	0.00801	CbGeAlD
Olopatadine—HRH1—tendon—systemic lupus erythematosus	0.00102	0.0055	CbGeAlD
Olopatadine—CYP3A4—kidney—systemic lupus erythematosus	0.000974	0.00527	CbGeAlD
Olopatadine—HRH1—lung—systemic lupus erythematosus	0.000893	0.00483	CbGeAlD
Olopatadine—HRH1—nervous system—systemic lupus erythematosus	0.000827	0.00447	CbGeAlD
Olopatadine—HRH1—central nervous system—systemic lupus erythematosus	0.000796	0.00431	CbGeAlD
Olopatadine—CYP3A4—nervous system—systemic lupus erythematosus	0.000639	0.00346	CbGeAlD
Olopatadine—CYP3A4—central nervous system—systemic lupus erythematosus	0.000616	0.00333	CbGeAlD
Olopatadine—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.000394	0.00141	CcSEcCtD
Olopatadine—Oedema—Mycophenolate mofetil—systemic lupus erythematosus	0.000392	0.0014	CcSEcCtD
Olopatadine—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.00039	0.0014	CcSEcCtD
Olopatadine—Infection—Mycophenolate mofetil—systemic lupus erythematosus	0.000389	0.00139	CcSEcCtD
Olopatadine—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000384	0.00138	CcSEcCtD
Olopatadine—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.000383	0.00137	CcSEcCtD
Olopatadine—Ill-defined disorder—Triamcinolone—systemic lupus erythematosus	0.000382	0.00137	CcSEcCtD
Olopatadine—Ill-defined disorder—Methylprednisolone—systemic lupus erythematosus	0.000381	0.00137	CcSEcCtD
Olopatadine—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00038	0.00136	CcSEcCtD
Olopatadine—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000377	0.00135	CcSEcCtD
Olopatadine—Discomfort—Prednisolone—systemic lupus erythematosus	0.000377	0.00135	CcSEcCtD
Olopatadine—Erythema—Dexamethasone—systemic lupus erythematosus	0.000373	0.00134	CcSEcCtD
Olopatadine—Erythema—Betamethasone—systemic lupus erythematosus	0.000373	0.00134	CcSEcCtD
Olopatadine—Asthenia—Leflunomide—systemic lupus erythematosus	0.000373	0.00134	CcSEcCtD
Olopatadine—Malaise—Triamcinolone—systemic lupus erythematosus	0.000371	0.00133	CcSEcCtD
Olopatadine—Malaise—Methylprednisolone—systemic lupus erythematosus	0.00037	0.00133	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.00037	0.00133	CcSEcCtD
Olopatadine—Pruritus—Leflunomide—systemic lupus erythematosus	0.000368	0.00132	CcSEcCtD
Olopatadine—Discomfort—Hydrocortisone—systemic lupus erythematosus	0.000368	0.00132	CcSEcCtD
Olopatadine—Oedema—Prednisolone—systemic lupus erythematosus	0.000365	0.00131	CcSEcCtD
Olopatadine—Dizziness—Azathioprine—systemic lupus erythematosus	0.000364	0.00131	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Methotrexate—systemic lupus erythematosus	0.000363	0.0013	CcSEcCtD
Olopatadine—Cough—Triamcinolone—systemic lupus erythematosus	0.000359	0.00129	CcSEcCtD
Olopatadine—Dyspnoea—Cyclosporine—systemic lupus erythematosus	0.000358	0.00128	CcSEcCtD
Olopatadine—Somnolence—Cyclosporine—systemic lupus erythematosus	0.000357	0.00128	CcSEcCtD
Olopatadine—Oedema—Hydrocortisone—systemic lupus erythematosus	0.000357	0.00128	CcSEcCtD
Olopatadine—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000356	0.00128	CcSEcCtD
Olopatadine—Infection—Hydrocortisone—systemic lupus erythematosus	0.000354	0.00127	CcSEcCtD
Olopatadine—Vomiting—Azathioprine—systemic lupus erythematosus	0.00035	0.00126	CcSEcCtD
Olopatadine—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.00035	0.00125	CcSEcCtD
Olopatadine—Eye disorder—Prednisone—systemic lupus erythematosus	0.000349	0.00125	CcSEcCtD
Olopatadine—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000349	0.00125	CcSEcCtD
Olopatadine—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	0.000348	0.00125	CcSEcCtD
Olopatadine—Infestation NOS—Methotrexate—systemic lupus erythematosus	0.000348	0.00125	CcSEcCtD
Olopatadine—Infestation—Methotrexate—systemic lupus erythematosus	0.000348	0.00125	CcSEcCtD
Olopatadine—Rash—Azathioprine—systemic lupus erythematosus	0.000347	0.00125	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000347	0.00125	CcSEcCtD
Olopatadine—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000347	0.00124	CcSEcCtD
Olopatadine—Depression—Methotrexate—systemic lupus erythematosus	0.000347	0.00124	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000347	0.00124	CcSEcCtD
Olopatadine—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000347	0.00124	CcSEcCtD
Olopatadine—Ill-defined disorder—Betamethasone—systemic lupus erythematosus	0.000347	0.00124	CcSEcCtD
Olopatadine—Ill-defined disorder—Dexamethasone—systemic lupus erythematosus	0.000347	0.00124	CcSEcCtD
Olopatadine—Discomfort—Triamcinolone—systemic lupus erythematosus	0.000346	0.00124	CcSEcCtD
Olopatadine—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000346	0.00124	CcSEcCtD
Olopatadine—Discomfort—Methylprednisolone—systemic lupus erythematosus	0.000345	0.00124	CcSEcCtD
Olopatadine—Headache—Azathioprine—systemic lupus erythematosus	0.000345	0.00124	CcSEcCtD
Olopatadine—Dizziness—Leflunomide—systemic lupus erythematosus	0.000344	0.00123	CcSEcCtD
Olopatadine—Pain—Cyclosporine—systemic lupus erythematosus	0.000343	0.00123	CcSEcCtD
Olopatadine—Dry mouth—Triamcinolone—systemic lupus erythematosus	0.000343	0.00123	CcSEcCtD
Olopatadine—Conjunctivitis—Methotrexate—systemic lupus erythematosus	0.000338	0.00121	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000338	0.00121	CcSEcCtD
Olopatadine—Immune system disorder—Prednisone—systemic lupus erythematosus	0.000337	0.00121	CcSEcCtD
Olopatadine—Malaise—Betamethasone—systemic lupus erythematosus	0.000337	0.00121	CcSEcCtD
Olopatadine—Malaise—Dexamethasone—systemic lupus erythematosus	0.000337	0.00121	CcSEcCtD
Olopatadine—Oedema—Triamcinolone—systemic lupus erythematosus	0.000336	0.0012	CcSEcCtD
Olopatadine—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000335	0.0012	CcSEcCtD
Olopatadine—Infection—Triamcinolone—systemic lupus erythematosus	0.000334	0.0012	CcSEcCtD
Olopatadine—Infection—Methylprednisolone—systemic lupus erythematosus	0.000333	0.00119	CcSEcCtD
Olopatadine—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000331	0.00119	CcSEcCtD
Olopatadine—Vomiting—Leflunomide—systemic lupus erythematosus	0.000331	0.00119	CcSEcCtD
Olopatadine—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000329	0.00118	CcSEcCtD
Olopatadine—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000328	0.00118	CcSEcCtD
Olopatadine—Epistaxis—Methotrexate—systemic lupus erythematosus	0.000328	0.00118	CcSEcCtD
Olopatadine—Rash—Leflunomide—systemic lupus erythematosus	0.000328	0.00118	CcSEcCtD
Olopatadine—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000328	0.00117	CcSEcCtD
Olopatadine—Nausea—Azathioprine—systemic lupus erythematosus	0.000327	0.00117	CcSEcCtD
Olopatadine—Headache—Leflunomide—systemic lupus erythematosus	0.000326	0.00117	CcSEcCtD
Olopatadine—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000326	0.00117	CcSEcCtD
Olopatadine—Erythema—Prednisone—systemic lupus erythematosus	0.000325	0.00117	CcSEcCtD
Olopatadine—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000323	0.00116	CcSEcCtD
Olopatadine—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00032	0.00115	CcSEcCtD
Olopatadine—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000317	0.00114	CcSEcCtD
Olopatadine—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000317	0.00114	CcSEcCtD
Olopatadine—Discomfort—Betamethasone—systemic lupus erythematosus	0.000314	0.00113	CcSEcCtD
Olopatadine—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000314	0.00113	CcSEcCtD
Olopatadine—Pain—Prednisolone—systemic lupus erythematosus	0.000312	0.00112	CcSEcCtD
Olopatadine—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.00031	0.00111	CcSEcCtD
Olopatadine—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00031	0.00111	CcSEcCtD
Olopatadine—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.00031	0.00111	CcSEcCtD
Olopatadine—Nausea—Leflunomide—systemic lupus erythematosus	0.000309	0.00111	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000308	0.0011	CcSEcCtD
Olopatadine—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000308	0.0011	CcSEcCtD
Olopatadine—Vision blurred—Prednisone—systemic lupus erythematosus	0.000307	0.0011	CcSEcCtD
Olopatadine—Pain—Hydrocortisone—systemic lupus erythematosus	0.000305	0.00109	CcSEcCtD
Olopatadine—Oedema—Dexamethasone—systemic lupus erythematosus	0.000305	0.00109	CcSEcCtD
Olopatadine—Oedema—Betamethasone—systemic lupus erythematosus	0.000305	0.00109	CcSEcCtD
Olopatadine—Infection—Dexamethasone—systemic lupus erythematosus	0.000303	0.00109	CcSEcCtD
Olopatadine—Infection—Betamethasone—systemic lupus erythematosus	0.000303	0.00109	CcSEcCtD
Olopatadine—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000302	0.00108	CcSEcCtD
Olopatadine—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000301	0.00108	CcSEcCtD
Olopatadine—Visual impairment—Methotrexate—systemic lupus erythematosus	0.000301	0.00108	CcSEcCtD
Olopatadine—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.0003	0.00107	CcSEcCtD
Olopatadine—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000299	0.00107	CcSEcCtD
Olopatadine—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000299	0.00107	CcSEcCtD
Olopatadine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000296	0.00106	CcSEcCtD
Olopatadine—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000294	0.00105	CcSEcCtD
Olopatadine—Malaise—Prednisone—systemic lupus erythematosus	0.000293	0.00105	CcSEcCtD
Olopatadine—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000292	0.00105	CcSEcCtD
Olopatadine—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000292	0.00105	CcSEcCtD
Olopatadine—Fatigue—Triamcinolone—systemic lupus erythematosus	0.00029	0.00104	CcSEcCtD
Olopatadine—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000289	0.00104	CcSEcCtD
Olopatadine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000289	0.00103	CcSEcCtD
Olopatadine—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000288	0.00103	CcSEcCtD
Olopatadine—Pain—Triamcinolone—systemic lupus erythematosus	0.000287	0.00103	CcSEcCtD
Olopatadine—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000284	0.00102	CcSEcCtD
Olopatadine—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000282	0.00101	CcSEcCtD
Olopatadine—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000282	0.00101	CcSEcCtD
Olopatadine—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000282	0.00101	CcSEcCtD
Olopatadine—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000281	0.00101	CcSEcCtD
Olopatadine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000281	0.00101	CcSEcCtD
Olopatadine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000277	0.000993	CcSEcCtD
Olopatadine—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000277	0.000993	CcSEcCtD
Olopatadine—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000276	0.00099	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000275	0.000986	CcSEcCtD
Olopatadine—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000275	0.000985	CcSEcCtD
Olopatadine—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000274	0.000983	CcSEcCtD
Olopatadine—Discomfort—Prednisone—systemic lupus erythematosus	0.000274	0.000981	CcSEcCtD
Olopatadine—Erythema—Methotrexate—systemic lupus erythematosus	0.000272	0.000975	CcSEcCtD
Olopatadine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000269	0.000965	CcSEcCtD
Olopatadine—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000268	0.000961	CcSEcCtD
Olopatadine—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.000266	0.000954	CcSEcCtD
Olopatadine—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000266	0.000952	CcSEcCtD
Olopatadine—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000265	0.000952	CcSEcCtD
Olopatadine—Oedema—Prednisone—systemic lupus erythematosus	0.000265	0.000952	CcSEcCtD
Olopatadine—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000265	0.00095	CcSEcCtD
Olopatadine—Infection—Prednisone—systemic lupus erythematosus	0.000264	0.000946	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000263	0.000944	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000263	0.000944	CcSEcCtD
Olopatadine—Back pain—Methotrexate—systemic lupus erythematosus	0.000263	0.000943	CcSEcCtD
Olopatadine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000263	0.000942	CcSEcCtD
Olopatadine—Fatigue—Betamethasone—systemic lupus erythematosus	0.000263	0.000942	CcSEcCtD
Olopatadine—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000263	0.000942	CcSEcCtD
Olopatadine—Pain—Dexamethasone—systemic lupus erythematosus	0.000261	0.000935	CcSEcCtD
Olopatadine—Pain—Betamethasone—systemic lupus erythematosus	0.000261	0.000935	CcSEcCtD
Olopatadine—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.00026	0.000933	CcSEcCtD
Olopatadine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000259	0.000929	CcSEcCtD
Olopatadine—Skin disorder—Prednisone—systemic lupus erythematosus	0.000258	0.000925	CcSEcCtD
Olopatadine—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000256	0.000919	CcSEcCtD
Olopatadine—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000256	0.000918	CcSEcCtD
Olopatadine—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000255	0.000915	CcSEcCtD
Olopatadine—Rash—Cyclosporine—systemic lupus erythematosus	0.000253	0.000908	CcSEcCtD
Olopatadine—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000253	0.000907	CcSEcCtD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—systemic lupus erythematosus	0.000253	0.000722	CbGpPWpGaD
Olopatadine—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000252	0.000905	CcSEcCtD
Olopatadine—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000252	0.000904	CcSEcCtD
Olopatadine—Headache—Cyclosporine—systemic lupus erythematosus	0.000251	0.000902	CcSEcCtD
Olopatadine—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000251	0.000901	CcSEcCtD
Olopatadine—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000251	0.000901	CcSEcCtD
Olopatadine—S100A12—Immune System—CFB—systemic lupus erythematosus	0.000251	0.000717	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TLR6—systemic lupus erythematosus	0.000251	0.000717	CbGpPWpGaD
Olopatadine—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000249	0.000894	CcSEcCtD
Olopatadine—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000249	0.000894	CcSEcCtD
Olopatadine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000249	0.000893	CcSEcCtD
Olopatadine—S100B—Immune System—CR1—systemic lupus erythematosus	0.000249	0.000711	CbGpPWpGaD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—IL6—systemic lupus erythematosus	0.000249	0.000711	CbGpPWpGaD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—IL6—systemic lupus erythematosus	0.000248	0.000709	CbGpPWpGaD
Olopatadine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000248	0.000887	CcSEcCtD
Olopatadine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000247	0.000885	CcSEcCtD
Olopatadine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000247	0.000885	CcSEcCtD
Olopatadine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000247	0.000885	CcSEcCtD
Olopatadine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000245	0.00088	CcSEcCtD
Olopatadine—Malaise—Methotrexate—systemic lupus erythematosus	0.000245	0.000879	CcSEcCtD
Olopatadine—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000244	0.000875	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—HMGB1—systemic lupus erythematosus	0.000244	0.000697	CbGpPWpGaD
Olopatadine—Dizziness—Prednisolone—systemic lupus erythematosus	0.000242	0.000866	CcSEcCtD
Olopatadine—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000241	0.000864	CcSEcCtD
Olopatadine—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000241	0.000864	CcSEcCtD
Olopatadine—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000241	0.000864	CcSEcCtD
Olopatadine—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000241	0.000864	CcSEcCtD
Olopatadine—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000241	0.000864	CcSEcCtD
Olopatadine—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.00024	0.000862	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—IFNA1—systemic lupus erythematosus	0.00024	0.000685	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—IL6—systemic lupus erythematosus	0.000239	0.000684	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—IL6—systemic lupus erythematosus	0.000239	0.000682	CbGpPWpGaD
Olopatadine—Nausea—Cyclosporine—systemic lupus erythematosus	0.000238	0.000855	CcSEcCtD
Olopatadine—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000238	0.000852	CcSEcCtD
Olopatadine—S100B—Immune System—CFB—systemic lupus erythematosus	0.000237	0.000678	CbGpPWpGaD
Olopatadine—S100B—Immune System—TLR6—systemic lupus erythematosus	0.000237	0.000678	CbGpPWpGaD
Olopatadine—Cough—Methotrexate—systemic lupus erythematosus	0.000237	0.000851	CcSEcCtD
Olopatadine—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000237	0.00085	CcSEcCtD
Olopatadine—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000236	0.000846	CcSEcCtD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—IL6—systemic lupus erythematosus	0.000235	0.000672	CbGpPWpGaD
Olopatadine—S100A12—Immune System—FCGR3A—systemic lupus erythematosus	0.000234	0.00067	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—RASGRP1—systemic lupus erythematosus	0.000233	0.000667	CbGpPWpGaD
Olopatadine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000233	0.000834	CcSEcCtD
Olopatadine—S100A12—Immune System—RIPK1—systemic lupus erythematosus	0.000232	0.000662	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—HMGB1—systemic lupus erythematosus	0.000231	0.000659	CbGpPWpGaD
Olopatadine—Rash—Prednisolone—systemic lupus erythematosus	0.00023	0.000826	CcSEcCtD
Olopatadine—Dermatitis—Prednisolone—systemic lupus erythematosus	0.00023	0.000825	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.00023	0.000824	CcSEcCtD
Olopatadine—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000229	0.000822	CcSEcCtD
Olopatadine—Fatigue—Prednisone—systemic lupus erythematosus	0.000229	0.000821	CcSEcCtD
Olopatadine—Headache—Prednisolone—systemic lupus erythematosus	0.000229	0.000821	CcSEcCtD
Olopatadine—Discomfort—Methotrexate—systemic lupus erythematosus	0.000229	0.00082	CcSEcCtD
Olopatadine—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000227	0.000813	CcSEcCtD
Olopatadine—S100B—Innate Immune System—IFNA1—systemic lupus erythematosus	0.000227	0.000648	CbGpPWpGaD
Olopatadine—S100B—MyD88-independent cascade—IL6—systemic lupus erythematosus	0.000226	0.000645	CbGpPWpGaD
Olopatadine—Rash—Hydrocortisone—systemic lupus erythematosus	0.000225	0.000807	CcSEcCtD
Olopatadine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000225	0.000806	CcSEcCtD
Olopatadine—S100A12—Immune System—TLR9—systemic lupus erythematosus	0.000224	0.000639	CbGpPWpGaD
Olopatadine—Headache—Hydrocortisone—systemic lupus erythematosus	0.000224	0.000801	CcSEcCtD
Olopatadine—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000223	0.000638	CbGpPWpGaD
Olopatadine—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000222	0.000797	CcSEcCtD
Olopatadine—S100B—Immune System—FCGR3A—systemic lupus erythematosus	0.000222	0.000633	CbGpPWpGaD
Olopatadine—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000222	0.000795	CcSEcCtD
Olopatadine—S100B—Innate Immune System—RASGRP1—systemic lupus erythematosus	0.000221	0.000631	CbGpPWpGaD
Olopatadine—Infection—Methotrexate—systemic lupus erythematosus	0.00022	0.00079	CcSEcCtD
Olopatadine—S100B—Immune System—RIPK1—systemic lupus erythematosus	0.000219	0.000626	CbGpPWpGaD
Olopatadine—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000219	0.000784	CcSEcCtD
Olopatadine—Asthenia—Betamethasone—systemic lupus erythematosus	0.000219	0.000784	CcSEcCtD
Olopatadine—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000219	0.000784	CcSEcCtD
Olopatadine—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000218	0.00078	CcSEcCtD
Olopatadine—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000217	0.000778	CcSEcCtD
Olopatadine—Nausea—Prednisolone—systemic lupus erythematosus	0.000217	0.000778	CcSEcCtD
Olopatadine—Pruritus—Betamethasone—systemic lupus erythematosus	0.000216	0.000773	CcSEcCtD
Olopatadine—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000216	0.000773	CcSEcCtD
Olopatadine—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000215	0.000773	CcSEcCtD
Olopatadine—S100A12—Activated TLR4 signalling—IL6—systemic lupus erythematosus	0.000215	0.000613	CbGpPWpGaD
Olopatadine—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000214	0.000766	CcSEcCtD
Olopatadine—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000213	0.000764	CcSEcCtD
Olopatadine—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000212	0.00076	CcSEcCtD
Olopatadine—Rash—Triamcinolone—systemic lupus erythematosus	0.000212	0.000759	CcSEcCtD
Olopatadine—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000212	0.000759	CcSEcCtD
Olopatadine—S100B—Immune System—TLR9—systemic lupus erythematosus	0.000212	0.000604	CbGpPWpGaD
Olopatadine—Rash—Methylprednisolone—systemic lupus erythematosus	0.000211	0.000758	CcSEcCtD
Olopatadine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000211	0.000757	CcSEcCtD
Olopatadine—Headache—Triamcinolone—systemic lupus erythematosus	0.00021	0.000755	CcSEcCtD
Olopatadine—Headache—Methylprednisolone—systemic lupus erythematosus	0.00021	0.000753	CcSEcCtD
Olopatadine—Body temperature increased—Prednisone—systemic lupus erythematosus	0.00021	0.000752	CcSEcCtD
Olopatadine—Abdominal pain—Prednisone—systemic lupus erythematosus	0.00021	0.000752	CcSEcCtD
Olopatadine—HRH1—IL-4 Signaling Pathway—TYK2—systemic lupus erythematosus	0.000209	0.000598	CbGpPWpGaD
Olopatadine—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000209	0.000748	CcSEcCtD
Olopatadine—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000209	0.000748	CcSEcCtD
Olopatadine—S100B—Activated TLR4 signalling—IL6—systemic lupus erythematosus	0.000203	0.00058	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—IL6—systemic lupus erythematosus	0.000202	0.000577	CbGpPWpGaD
Olopatadine—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000202	0.000723	CcSEcCtD
Olopatadine—Dizziness—Betamethasone—systemic lupus erythematosus	0.000202	0.000723	CcSEcCtD
Olopatadine—Nausea—Triamcinolone—systemic lupus erythematosus	0.0002	0.000715	CcSEcCtD
Olopatadine—S100A12—Immune System—CSK—systemic lupus erythematosus	0.000199	0.00057	CbGpPWpGaD
Olopatadine—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000199	0.000714	CcSEcCtD
Olopatadine—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000198	0.000709	CcSEcCtD
Olopatadine—S100A12—Immune System—MBL2—systemic lupus erythematosus	0.000198	0.000565	CbGpPWpGaD
Olopatadine—Somnolence—Methotrexate—systemic lupus erythematosus	0.000197	0.000707	CcSEcCtD
Olopatadine—S100A12—Immune System—IRF5—systemic lupus erythematosus	0.000196	0.00056	CbGpPWpGaD
Olopatadine—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000196	0.000701	CcSEcCtD
Olopatadine—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000194	0.000695	CcSEcCtD
Olopatadine—Vomiting—Betamethasone—systemic lupus erythematosus	0.000194	0.000695	CcSEcCtD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000193	0.000551	CbGpPWpGaD
Olopatadine—Rash—Betamethasone—systemic lupus erythematosus	0.000192	0.000689	CcSEcCtD
Olopatadine—Rash—Dexamethasone—systemic lupus erythematosus	0.000192	0.000689	CcSEcCtD
Olopatadine—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000192	0.000688	CcSEcCtD
Olopatadine—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000192	0.000688	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000192	0.000687	CcSEcCtD
Olopatadine—Fatigue—Methotrexate—systemic lupus erythematosus	0.000191	0.000686	CcSEcCtD
Olopatadine—Headache—Dexamethasone—systemic lupus erythematosus	0.000191	0.000685	CcSEcCtD
Olopatadine—Headache—Betamethasone—systemic lupus erythematosus	0.000191	0.000685	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—IL6—systemic lupus erythematosus	0.000191	0.000546	CbGpPWpGaD
Olopatadine—Asthenia—Prednisone—systemic lupus erythematosus	0.00019	0.000683	CcSEcCtD
Olopatadine—Pain—Methotrexate—systemic lupus erythematosus	0.00019	0.00068	CcSEcCtD
Olopatadine—S100B—Immune System—CSK—systemic lupus erythematosus	0.000189	0.000539	CbGpPWpGaD
Olopatadine—Pruritus—Prednisone—systemic lupus erythematosus	0.000188	0.000673	CcSEcCtD
Olopatadine—S100A12—Immune System—IRF8—systemic lupus erythematosus	0.000187	0.000536	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFIH1—systemic lupus erythematosus	0.000187	0.000536	CbGpPWpGaD
Olopatadine—S100A12—Immune System—ITGAM—systemic lupus erythematosus	0.000187	0.000536	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD247—systemic lupus erythematosus	0.000187	0.000536	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.000187	0.000534	CbGpPWpGaD
Olopatadine—S100B—Immune System—MBL2—systemic lupus erythematosus	0.000187	0.000534	CbGpPWpGaD
Olopatadine—S100B—Immune System—IRF5—systemic lupus erythematosus	0.000185	0.00053	CbGpPWpGaD
Olopatadine—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000183	0.000655	CcSEcCtD
Olopatadine—S100A12—Immune System—NCF2—systemic lupus erythematosus	0.000182	0.000521	CbGpPWpGaD
Olopatadine—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000182	0.000651	CcSEcCtD
Olopatadine—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000181	0.00065	CcSEcCtD
Olopatadine—S100A12—Immune System—LYN—systemic lupus erythematosus	0.000181	0.000518	CbGpPWpGaD
Olopatadine—Nausea—Dexamethasone—systemic lupus erythematosus	0.000181	0.000649	CcSEcCtD
Olopatadine—Nausea—Betamethasone—systemic lupus erythematosus	0.000181	0.000649	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—JAK1—systemic lupus erythematosus	0.000181	0.000517	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—IL6—systemic lupus erythematosus	0.00018	0.000514	CbGpPWpGaD
Olopatadine—S100A12—Immune System—FCGR2A—systemic lupus erythematosus	0.000179	0.000511	CbGpPWpGaD
Olopatadine—S100B—Immune System—IRF8—systemic lupus erythematosus	0.000177	0.000506	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD247—systemic lupus erythematosus	0.000177	0.000506	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFIH1—systemic lupus erythematosus	0.000177	0.000506	CbGpPWpGaD
Olopatadine—S100B—Immune System—ITGAM—systemic lupus erythematosus	0.000177	0.000506	CbGpPWpGaD
Olopatadine—Dizziness—Prednisone—systemic lupus erythematosus	0.000176	0.000629	CcSEcCtD
Olopatadine—S100A12—Immune System—TNFAIP3—systemic lupus erythematosus	0.000176	0.000501	CbGpPWpGaD
Olopatadine—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000175	0.000629	CcSEcCtD
Olopatadine—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000175	0.000629	CcSEcCtD
Olopatadine—S100A12—Immune System—BLK—systemic lupus erythematosus	0.000173	0.000496	CbGpPWpGaD
Olopatadine—S100B—Immune System—NCF2—systemic lupus erythematosus	0.000172	0.000493	CbGpPWpGaD
Olopatadine—S100B—Immune System—LYN—systemic lupus erythematosus	0.000171	0.000489	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—JAK1—systemic lupus erythematosus	0.000171	0.000489	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—IL6—systemic lupus erythematosus	0.00017	0.000486	CbGpPWpGaD
Olopatadine—S100B—Immune System—FCGR2A—systemic lupus erythematosus	0.000169	0.000483	CbGpPWpGaD
Olopatadine—Vomiting—Prednisone—systemic lupus erythematosus	0.000169	0.000605	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—C3—systemic lupus erythematosus	0.000168	0.000479	CbGpPWpGaD
Olopatadine—Rash—Prednisone—systemic lupus erythematosus	0.000167	0.0006	CcSEcCtD
Olopatadine—Dermatitis—Prednisone—systemic lupus erythematosus	0.000167	0.0006	CcSEcCtD
Olopatadine—Headache—Prednisone—systemic lupus erythematosus	0.000166	0.000596	CcSEcCtD
Olopatadine—S100B—Immune System—TNFAIP3—systemic lupus erythematosus	0.000166	0.000474	CbGpPWpGaD
Olopatadine—S100B—Immune System—BLK—systemic lupus erythematosus	0.000164	0.000469	CbGpPWpGaD
Olopatadine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000163	0.000586	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.00016	0.000458	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—IL6—systemic lupus erythematosus	0.00016	0.000458	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CRP—systemic lupus erythematosus	0.000159	0.000456	CbGpPWpGaD
Olopatadine—Asthenia—Methotrexate—systemic lupus erythematosus	0.000159	0.000571	CcSEcCtD
Olopatadine—S100B—Innate Immune System—C3—systemic lupus erythematosus	0.000159	0.000453	CbGpPWpGaD
Olopatadine—Nausea—Prednisone—systemic lupus erythematosus	0.000158	0.000565	CcSEcCtD
Olopatadine—Pruritus—Methotrexate—systemic lupus erythematosus	0.000157	0.000563	CcSEcCtD
Olopatadine—HRH1—IL-4 Signaling Pathway—EP300—systemic lupus erythematosus	0.000156	0.000446	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PTPRC—systemic lupus erythematosus	0.000155	0.000443	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL1RN—systemic lupus erythematosus	0.000154	0.000441	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—TLR4—systemic lupus erythematosus	0.000153	0.000437	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.000152	0.000434	CbGpPWpGaD
Olopatadine—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000152	0.000544	CcSEcCtD
Olopatadine—S100B—Innate Immune System—CRP—systemic lupus erythematosus	0.000151	0.000431	CbGpPWpGaD
Olopatadine—Dizziness—Methotrexate—systemic lupus erythematosus	0.000147	0.000526	CcSEcCtD
Olopatadine—S100B—Immune System—PTPRC—systemic lupus erythematosus	0.000147	0.000419	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL1RN—systemic lupus erythematosus	0.000146	0.000417	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—TLR4—systemic lupus erythematosus	0.000145	0.000413	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD40—systemic lupus erythematosus	0.000144	0.000412	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HMGB1—systemic lupus erythematosus	0.000142	0.000406	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CTLA4—systemic lupus erythematosus	0.000142	0.000406	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CD80—systemic lupus erythematosus	0.000141	0.000403	CbGpPWpGaD
Olopatadine—Vomiting—Methotrexate—systemic lupus erythematosus	0.000141	0.000506	CcSEcCtD
Olopatadine—Rash—Methotrexate—systemic lupus erythematosus	0.00014	0.000502	CcSEcCtD
Olopatadine—Dermatitis—Methotrexate—systemic lupus erythematosus	0.00014	0.000501	CcSEcCtD
Olopatadine—S100A12—Immune System—IFNA1—systemic lupus erythematosus	0.00014	0.000399	CbGpPWpGaD
Olopatadine—Headache—Methotrexate—systemic lupus erythematosus	0.000139	0.000498	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000137	0.000391	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD40—systemic lupus erythematosus	0.000136	0.000389	CbGpPWpGaD
Olopatadine—S100A12—Immune System—RASGRP1—systemic lupus erythematosus	0.000136	0.000388	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.000136	0.000388	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD79A—systemic lupus erythematosus	0.000136	0.000387	CbGpPWpGaD
Olopatadine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000135	0.000386	CbGpPWpGaD
Olopatadine—S100B—Immune System—CTLA4—systemic lupus erythematosus	0.000134	0.000384	CbGpPWpGaD
Olopatadine—S100B—Immune System—HMGB1—systemic lupus erythematosus	0.000134	0.000384	CbGpPWpGaD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000134	0.000384	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CD80—systemic lupus erythematosus	0.000133	0.000381	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000132	0.000378	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFNA1—systemic lupus erythematosus	0.000132	0.000377	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PRL—systemic lupus erythematosus	0.000132	0.000377	CbGpPWpGaD
Olopatadine—Nausea—Methotrexate—systemic lupus erythematosus	0.000132	0.000472	CcSEcCtD
Olopatadine—S100B—Immune System—RASGRP1—systemic lupus erythematosus	0.000129	0.000367	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD79A—systemic lupus erythematosus	0.000128	0.000366	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000125	0.000357	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-DQA1—systemic lupus erythematosus	0.000125	0.000357	CbGpPWpGaD
Olopatadine—S100B—Immune System—PRL—systemic lupus erythematosus	0.000125	0.000356	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000122	0.000349	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CSK—systemic lupus erythematosus	0.000122	0.000348	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—TYK2—systemic lupus erythematosus	0.000119	0.00034	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-DQA1—systemic lupus erythematosus	0.000118	0.000338	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-DQB1—systemic lupus erythematosus	0.000117	0.000334	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—TYK2—systemic lupus erythematosus	0.000113	0.000322	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000111	0.000319	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL18—systemic lupus erythematosus	0.000111	0.000317	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—LYN—systemic lupus erythematosus	0.000111	0.000316	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-DQB1—systemic lupus erythematosus	0.000111	0.000316	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD40LG—systemic lupus erythematosus	0.00011	0.000316	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000109	0.000313	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD8A—systemic lupus erythematosus	0.000109	0.000312	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000109	0.00031	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000108	0.000308	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CD4—systemic lupus erythematosus	0.000108	0.000308	CbGpPWpGaD
Olopatadine—S100A12—Immune System—JAK1—systemic lupus erythematosus	0.000105	0.000301	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	0.000105	0.000301	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL18—systemic lupus erythematosus	0.000105	0.0003	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD40LG—systemic lupus erythematosus	0.000104	0.000298	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	0.000104	0.000296	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD8A—systemic lupus erythematosus	0.000103	0.000295	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000102	0.000292	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CD4—systemic lupus erythematosus	0.000102	0.000291	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CDKN1B—systemic lupus erythematosus	0.000101	0.000289	CbGpPWpGaD
Olopatadine—S100B—Immune System—JAK1—systemic lupus erythematosus	9.97e-05	0.000285	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL2RA—systemic lupus erythematosus	9.85e-05	0.000281	CbGpPWpGaD
Olopatadine—S100A12—Immune System—C3—systemic lupus erythematosus	9.76e-05	0.000279	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CDKN1B—systemic lupus erythematosus	9.58e-05	0.000274	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—F2—systemic lupus erythematosus	9.57e-05	0.000274	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CDKN1A—systemic lupus erythematosus	9.35e-05	0.000267	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL2RA—systemic lupus erythematosus	9.31e-05	0.000266	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CRP—systemic lupus erythematosus	9.29e-05	0.000265	CbGpPWpGaD
Olopatadine—S100B—Immune System—C3—systemic lupus erythematosus	9.23e-05	0.000264	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CXCL12—systemic lupus erythematosus	8.91e-05	0.000255	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TLR4—systemic lupus erythematosus	8.9e-05	0.000254	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-DRB1—systemic lupus erythematosus	8.89e-05	0.000254	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—EP300—systemic lupus erythematosus	8.89e-05	0.000254	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CDKN1A—systemic lupus erythematosus	8.84e-05	0.000253	CbGpPWpGaD
Olopatadine—S100B—Immune System—CRP—systemic lupus erythematosus	8.78e-05	0.000251	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—JUNB—systemic lupus erythematosus	8.75e-05	0.00025	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	8.62e-05	0.000246	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	8.56e-05	0.000245	CbGpPWpGaD
Olopatadine—S100B—Immune System—TLR4—systemic lupus erythematosus	8.42e-05	0.000241	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-DRB1—systemic lupus erythematosus	8.41e-05	0.00024	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—EP300—systemic lupus erythematosus	8.41e-05	0.00024	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.31e-05	0.000237	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD80—systemic lupus erythematosus	8.22e-05	0.000235	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCL12—systemic lupus erythematosus	8.21e-05	0.000235	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PRL—systemic lupus erythematosus	8.06e-05	0.00023	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD80—systemic lupus erythematosus	7.77e-05	0.000222	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	7.39e-05	0.000211	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	7.22e-05	0.000206	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TYK2—systemic lupus erythematosus	6.94e-05	0.000198	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	6.93e-05	0.000198	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	6.9e-05	0.000197	CbGpPWpGaD
Olopatadine—S100B—Immune System—TYK2—systemic lupus erythematosus	6.56e-05	0.000187	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFNG—systemic lupus erythematosus	6.5e-05	0.000186	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—JAK1—systemic lupus erythematosus	6.45e-05	0.000184	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	6.34e-05	0.000181	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD4—systemic lupus erythematosus	6.27e-05	0.000179	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—P2RY12—systemic lupus erythematosus	6.26e-05	0.000179	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFNG—systemic lupus erythematosus	6.14e-05	0.000176	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCR5—systemic lupus erythematosus	6.11e-05	0.000175	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.02e-05	0.000172	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—C3—systemic lupus erythematosus	5.97e-05	0.000171	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD4—systemic lupus erythematosus	5.93e-05	0.00017	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CDKN1B—systemic lupus erythematosus	5.9e-05	0.000169	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IL6—systemic lupus erythematosus	5.83e-05	0.000166	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	5.82e-05	0.000166	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL2—systemic lupus erythematosus	5.77e-05	0.000165	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	5.65e-05	0.000161	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCR5—systemic lupus erythematosus	5.63e-05	0.000161	CbGpPWpGaD
Olopatadine—S100B—Immune System—CDKN1B—systemic lupus erythematosus	5.58e-05	0.000159	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IL6—systemic lupus erythematosus	5.51e-05	0.000157	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—C3—systemic lupus erythematosus	5.5e-05	0.000157	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL2—systemic lupus erythematosus	5.46e-05	0.000156	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CDKN1A—systemic lupus erythematosus	5.44e-05	0.000156	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—F2—systemic lupus erythematosus	5.24e-05	0.00015	CbGpPWpGaD
Olopatadine—S100A12—Immune System—EP300—systemic lupus erythematosus	5.18e-05	0.000148	CbGpPWpGaD
Olopatadine—S100B—Immune System—CDKN1A—systemic lupus erythematosus	5.15e-05	0.000147	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CD80—systemic lupus erythematosus	5.02e-05	0.000144	CbGpPWpGaD
Olopatadine—Acepromazine—ALB—systemic lupus erythematosus	5.02e-05	0.251	CrCbGaD
Olopatadine—S100B—Immune System—EP300—systemic lupus erythematosus	4.9e-05	0.00014	CbGpPWpGaD
Olopatadine—Thiothixene—ALB—systemic lupus erythematosus	4.83e-05	0.242	CrCbGaD
Olopatadine—HRH1—GPCR ligand binding—F2—systemic lupus erythematosus	4.83e-05	0.000138	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCL2—systemic lupus erythematosus	4.67e-05	0.000133	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	4.64e-05	0.000133	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	4.33e-05	0.000124	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCL2—systemic lupus erythematosus	4.3e-05	0.000123	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TYK2—systemic lupus erythematosus	4.24e-05	0.000121	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	4.21e-05	0.00012	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NOS3—systemic lupus erythematosus	4.16e-05	0.000119	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	3.93e-05	0.000112	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TLR9—systemic lupus erythematosus	3.82e-05	0.000109	CbGpPWpGaD
Olopatadine—Clomipramine—ALB—systemic lupus erythematosus	3.82e-05	0.191	CrCbGaD
Olopatadine—Nortriptyline—ALB—systemic lupus erythematosus	3.73e-05	0.187	CrCbGaD
Olopatadine—HRH1—Signaling Pathways—P2RY12—systemic lupus erythematosus	3.7e-05	0.000106	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.61e-05	0.000103	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL2—systemic lupus erythematosus	3.53e-05	0.000101	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	3.49e-05	9.98e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CSK—systemic lupus erythematosus	3.4e-05	9.73e-05	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL6—systemic lupus erythematosus	3.39e-05	9.69e-05	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	3.39e-05	9.68e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	3.36e-05	9.59e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MMP9—systemic lupus erythematosus	3.34e-05	9.54e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.33e-05	9.51e-05	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6—systemic lupus erythematosus	3.21e-05	9.17e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	3.18e-05	9.09e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—EP300—systemic lupus erythematosus	3.17e-05	9.05e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	3.13e-05	8.95e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NCF2—systemic lupus erythematosus	3.11e-05	8.9e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—C3—systemic lupus erythematosus	3.11e-05	8.88e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LYN—systemic lupus erythematosus	3.09e-05	8.84e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—JAK1—systemic lupus erythematosus	3.05e-05	8.71e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SH2B3—systemic lupus erythematosus	3.03e-05	8.67e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—VEGFA—systemic lupus erythematosus	3e-05	8.57e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCR5—systemic lupus erythematosus	2.89e-05	8.25e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	2.85e-05	8.13e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—C3—systemic lupus erythematosus	2.82e-05	8.06e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.75e-05	7.87e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—F2—systemic lupus erythematosus	2.73e-05	7.8e-05	CbGpPWpGaD
Olopatadine—Amitriptyline—ALB—systemic lupus erythematosus	2.59e-05	0.13	CrCbGaD
Olopatadine—HRH1—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.49e-05	7.11e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—F2—systemic lupus erythematosus	2.48e-05	7.08e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JUNB—systemic lupus erythematosus	2.44e-05	6.98e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.32e-05	6.63e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRL—systemic lupus erythematosus	2.25e-05	6.43e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.21e-05	6.31e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6—systemic lupus erythematosus	2.07e-05	5.93e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.01e-05	5.73e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.84e-05	5.25e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JAK1—systemic lupus erythematosus	1.8e-05	5.14e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.77e-05	5.07e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR5—systemic lupus erythematosus	1.71e-05	4.87e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.68e-05	4.8e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL2—systemic lupus erythematosus	1.67e-05	4.77e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—C3—systemic lupus erythematosus	1.67e-05	4.76e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—F2—systemic lupus erythematosus	1.46e-05	4.18e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CD80—systemic lupus erythematosus	1.4e-05	4.01e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.3e-05	3.73e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.18e-05	3.38e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.16e-05	3.32e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.01e-05	2.88e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	9.95e-06	2.84e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL2—systemic lupus erythematosus	9.86e-06	2.82e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6—systemic lupus erythematosus	9.81e-06	2.8e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MMP9—systemic lupus erythematosus	9.33e-06	2.67e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.3e-06	2.66e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EP300—systemic lupus erythematosus	8.84e-06	2.53e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.38e-06	2.39e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.69e-06	2.2e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	6.28e-06	1.79e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6—systemic lupus erythematosus	5.79e-06	1.66e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	5.65e-06	1.61e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	5.4e-06	1.54e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	4.94e-06	1.41e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	4.11e-06	1.17e-05	CbGpPWpGaD
